Ironwood Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $565.6M | $1.08B | $593.4M |
| Jun 2022 | $442.8M | $975.7M | $504.4M |
| Sep 2022 | $449.3M | $1.04B | $574.2M |
| Dec 2022 | $448.1M | $1.10B | $656.2M |
| Mar 2023 | $448.4M | $1.16B | $740.3M |
| Jun 2023 | $948.9M | $603.2M | $175.3M |
| Sep 2023 | $847.3M | $524.1M | $110.2M |
| Dec 2023 | $817.4M | $471.1M | $92.2M |
| Mar 2024 | $769.3M | $438.8M | $121.5M |
| Jun 2024 | $717.3M | $395.6M | $105.5M |
| Sep 2024 | $700.9M | $389.5M | $88.2M |
| Dec 2024 | $652.2M | $350.9M | $88.6M |
| Mar 2025 | $661.3M | $327.2M | $108.5M |
| Jun 2025 | $651.1M | $342.9M | $92.9M |
| Sep 2025 | $660.2M | $396.1M | $140.4M |
| Dec 2025 | $658.7M | $396.9M | $215.5M |
| Mar 2026 | $651.7M | $434.6M | $220.5M |
| Jun 2026 | $447.0M | $285.1M | $79.1M |